130 related articles for article (PubMed ID: 25300790)
1. Cell viability assessment using the Alamar blue assay: a comparison of 2D and 3D cell culture models.
Bonnier F; Keating ME; Wróbel TP; Majzner K; Baranska M; Garcia-Munoz A; Blanco A; Byrne HJ
Toxicol In Vitro; 2015 Feb; 29(1):124-31. PubMed ID: 25300790
[TBL] [Abstract][Full Text] [Related]
2. Standard Operating Procedure to Optimize Resazurin-Based Viability Assays.
Petiti J; Revel L; Divieto C
Biosensors (Basel); 2024 Mar; 14(4):. PubMed ID: 38667149
[TBL] [Abstract][Full Text] [Related]
3. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays.
Rampersad SN
Sensors (Basel); 2012; 12(9):12347-60. PubMed ID: 23112716
[TBL] [Abstract][Full Text] [Related]
4. Label-free impedance flow cytometry for nanotoxicity screening.
Ostermann M; Sauter A; Xue Y; Birkeland E; Schoelermann J; Holst B; Cimpan MR
Sci Rep; 2020 Jan; 10(1):142. PubMed ID: 31924828
[TBL] [Abstract][Full Text] [Related]
5. A simple and rapid assay of lysosomal-targeting CDy6 for long-term real-time viability assessments in 2D and 3D in vitro culture models.
Kang C; Yun WS; Jeong YM
Sci Rep; 2023 Dec; 13(1):23038. PubMed ID: 38155155
[TBL] [Abstract][Full Text] [Related]
6. Selecting the appropriate indirect viability assay for 3D paper-based cultures: a data-driven study.
Sitte ZR; Larson TS; McIntosh JC; Sinanian M; Lockett MR
Analyst; 2023 May; 148(10):2245-2255. PubMed ID: 37073480
[TBL] [Abstract][Full Text] [Related]
7. Rapid Evaluation of Novel Therapeutic Strategies Using a 3D Collagen-Based Tissue-Like Model.
Maury P; Porcel E; Mau A; Lux F; Tillement O; Mahou P; Schanne-Klein MC; Lacombe S
Front Bioeng Biotechnol; 2021; 9():574035. PubMed ID: 33681152
[TBL] [Abstract][Full Text] [Related]
8. Cell Counting and Viability Assessment of 2D and 3D Cell Cultures: Expected Reliability of the Trypan Blue Assay.
Piccinini F; Tesei A; Arienti C; Bevilacqua A
Biol Proced Online; 2017; 19():8. PubMed ID: 28814944
[TBL] [Abstract][Full Text] [Related]
9. CALU-3 lung cells three-dimensionally assembled onto CellFate® matrix present angiotensin-converting enzyme-2 activity.
Dos Santos JF; Dos Reis EM; Berti FV; Colla G; Koepp J; Nunes VA
Biotechnol Bioeng; 2023 Dec; 120(12):3602-3611. PubMed ID: 37691178
[TBL] [Abstract][Full Text] [Related]
10. Effect of paclitaxel treatment on cellular mechanics and morphology of human oesophageal squamous cell carcinoma in 2D and 3D environments.
Kiwanuka M; Higgins G; Ngcobo S; Nagawa J; Lang DM; Zaman MH; Davies NH; Franz T
Integr Biol (Camb); 2022 Oct; 14(6):137-49. PubMed ID: 36244059
[TBL] [Abstract][Full Text] [Related]
11. Modeling Physiological Events in 2D vs. 3D Cell Culture.
Duval K; Grover H; Han LH; Mou Y; Pegoraro AF; Fredberg J; Chen Z
Physiology (Bethesda); 2017 Jul; 32(4):266-277. PubMed ID: 28615311
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Alamar Blue assay for cellular growth and viability in vitro.
Nakayama GR; Caton MC; Nova MP; Parandoosh Z
J Immunol Methods; 1997 May; 204(2):205-8. PubMed ID: 9212838
[No Abstract] [Full Text] [Related]
13. 3D Cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer.
Chambers KF; Mosaad EM; Russell PJ; Clements JA; Doran MR
PLoS One; 2014; 9(11):e111029. PubMed ID: 25380249
[TBL] [Abstract][Full Text] [Related]
14. The influence of anisotropic nano- to micro-topography on in vitro and in vivo osteogenesis.
Azeem A; English A; Kumar P; Satyam A; Biggs M; Jones E; Tripathi B; Basu N; Henkel J; Vaquette C; Rooney N; Riley G; O'Riordan A; Cross G; Ivanovski S; Hutmacher D; Pandit A; Zeugolis D
Nanomedicine (Lond); 2015; 10(5):693-711. PubMed ID: 25816874
[TBL] [Abstract][Full Text] [Related]
15. Accelerated Development of Supramolecular Corneal Stromal-Like Assemblies from Corneal Fibroblasts in the Presence of Macromolecular Crowders.
Kumar P; Satyam A; Fan X; Rochev Y; Rodriguez BJ; Gorelov A; Joshi L; Raghunath M; Pandit A; Zeugolis DI
Tissue Eng Part C Methods; 2015 Jul; 21(7):660-70. PubMed ID: 25535812
[TBL] [Abstract][Full Text] [Related]
16. The past, present and future in scaffold-based tendon treatments.
Lomas AJ; Ryan CN; Sorushanova A; Shologu N; Sideri AI; Tsioli V; Fthenakis GC; Tzora A; Skoufos I; Quinlan LR; O'Laighin G; Mullen AM; Kelly JL; Kearns S; Biggs M; Pandit A; Zeugolis DI
Adv Drug Deliv Rev; 2015 Apr; 84():257-77. PubMed ID: 25499820
[TBL] [Abstract][Full Text] [Related]
17. Hydrogels for 3D mammalian cell culture: a starting guide for laboratory practice.
Ruedinger F; Lavrentieva A; Blume C; Pepelanova I; Scheper T
Appl Microbiol Biotechnol; 2015 Jan; 99(2):623-36. PubMed ID: 25432676
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Validation of the Presto Blue Metabolic Assay for Online Monitoring of Cell Proliferation in a 3D Perfusion Bioreactor System.
Sonnaert M; Papantoniou I; Luyten FP; Schrooten JI
Tissue Eng Part C Methods; 2015 Jun; 21(6):519-29. PubMed ID: 25336207
[TBL] [Abstract][Full Text] [Related]
19. Basic Colorimetric Proliferation Assays: MTT, WST, and Resazurin.
Präbst K; Engelhardt H; Ringgeler S; Hübner H
Methods Mol Biol; 2017; 1601():1-17. PubMed ID: 28470513
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
